Nonalcoholic Steatohepatitis in Chinese Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorHumanity and Health Research Centre

About this trial

Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potentially serious condition with significantly risk of morbidity and mortality.

A growing body of evidence suggests that children with NASH frequently show histopathological features that differ from those of adults. The prevalence of this pattern in a wide range of paediatric cases as well as other histopathological lesions and their relevance and prognostic significance in children with NAFLD remains to be determined. Thus the investigators would like to conduct a study of biopsies and clinical information to document the histological features of paediatric NAFLD, to explore the natural history of paediatric NAFLD, and to determine the frequency and prognostic value of these features.

Eligibility criteria

Qualifiers

age 1-18 with biopsy-proven NAFLD

Alcohol consumption less than 20g/day and 10g/day for boys and girls respectively

Disqualifiers

with viral hepatitis, e.g. HBV, HCV

with a1-anti-trypsin disease

with autoimmune hepatitis

with Wilson disease

Trial design

Treatments tested in this trial

  • No intervention

Treatment groups

No treatment groups listed

Sponsors and collaborators

Humanity and Health Research Centre

Lead sponsor

Beijing 302 Hospital

Collaborator